SW

Shagun Wason

Active Director Director DIN 00845149
DIN 00845149 First appointment Jun 2003 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Jun 2003
Shareholding value •••• Premium profile

About Shagun Wason

Data last updated:

Shagun Wason is a Director at Ryesino Pharmaceuticals Private Limited (since 2003). The company operates in Pharma. Ryesino Pharmaceuticals Private Limited reported revenue of ₹14.49 Cr (FY 2024).

DIN 00845149
Primary Designation Director
Industry Pharma
First Appointment 01 Jun 2003
Oldest Company Age 42 yrs
Largest company Ryesino Pharmaceuticals Private Limited · ₹14.49 Cr (FY 2024)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director01 Jun 20031983₹14.49 Cr (FY 2024)Active

Board colleagues of Shagun Wason

Directorship timeline

Open interactive timeline →
Ryesino Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Shagun Wason

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Shagun Wason

Shagun Wason currently holds 1 directorship: Ryesino Pharmaceuticals Private Limited (Director, since 01 Jun 2003, revenue ₹14.49 Cr (FY 2024)).

Shagun Wason was first appointed on 01 Jun 2003 as Director at Ryesino Pharmaceuticals Private Limited.

The current boards of Shagun Wason's companies include Jaidesh Pal Wason (Ryesino Pharmaceuticals Private Limited), Renu Wason (Ryesino Pharmaceuticals Private Limited), Sachin Wason (Ryesino Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available